Atlas Trials

Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19

Clinical trial NCT04390139 · COMPLETED

Trial details

NCT number
NCT04390139
Sponsor
Banc de Sang i Teixits
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19SARS-CoV 2Adult Respiratory Distress Syndrome
Start date
2020-05-13
Primary completion
2022-12-20
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.